Hyperglycemia Is Associated with Psoriatic Inflammation in Both Humans and Mice.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
06 2019
Historique:
received: 03 08 2018
revised: 16 01 2019
accepted: 25 01 2019
pubmed: 19 2 2019
medline: 10 5 2020
entrez: 19 2 2019
Statut: ppublish

Résumé

Chronic low-grade inflammation can cause several metabolic syndromes. Patients with psoriasis, a chronic immunological skin inflammation, often develop diabetes. However, it is not clear to date how psoriasis leads to, or is correlated with, glucose intolerance. Here, we investigate whether psoriasis itself is correlated with hyperglycemia in humans and mice. In patients, the severity of psoriasis was correlated with high blood glucose levels, and treatment of psoriasis by phototherapy improved insulin secretion. Imiquimod-induced systemic and cutaneous inflammation in mice, with features of human psoriasis, also resulted in hyperglycemia. Although it should be determined if psoriasis-like cutaneous inflammation alone can induce hyperglycemia, imiquimod-treated mice showed impairment of insulin secretion without significant islet inflammation. Administration of anti-IL-17A monoclonal antibody improved hyperglycemia in patients with psoriasis and imiquimod-treated mice with psoriasiform features. These results suggest that hyperglycemia is highly associated with psoriasis, mainly through IL-17.

Identifiants

pubmed: 30776434
pii: S0022-202X(19)30117-4
doi: 10.1016/j.jid.2019.01.029
pii:
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0
IL17A protein, human 0
Il17a protein, mouse 0
Insulin 0
Interleukin-17 0
hemoglobin A1c protein, human 0
Imiquimod P1QW714R7M

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1329-1338.e7

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Kyoko Ikumi (K)

Department of Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Mizuyu Odanaka (M)

Department of Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Hiroaki Shime (H)

Department of Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Masaki Imai (M)

Department of Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Satoshi Osaga (S)

Clinical Research Management Center, Nagoya City University Hospital, Nagoya, Japan.

Osamu Taguchi (O)

Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Emi Nishida (E)

Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Hiroaki Hemmi (H)

Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan; Laboratory for Immune Regulation, World Premier International Research Center Initiative, Immunology Frontier Research Center, Osaka University, Osaka, Japan.

Tsuneyasu Kaisho (T)

Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan; Laboratory for Immune Regulation, World Premier International Research Center Initiative, Immunology Frontier Research Center, Osaka University, Osaka, Japan.

Akimichi Morita (A)

Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Electronic address: amorita@med.nagoya-cu.ac.jp.

Sayuri Yamazaki (S)

Department of Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Electronic address: yamazas@med.nagoya-cu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH